DreamCIS Inc
223250
Company Profile
Business description
DreamCIS Inc operates as a contract research organization. It provides experience services in Therapeutic Areas; Clinical Trial/Late Phase Study; Oncology; Cardiovascular; Endocrinology; and Rare Disease. It provides its services to clinical development; stand alone services; medical devices; and consulting.
Contact
130, Sajik-ro
Jongno-gu
Jeokseon-Hyundai Building, 10th Floor
Seoul
KORT: +82 220104500
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2025
Employees
372
Stocks News & Analysis
stocks
Going into earnings, is Netflix stock a buy, a sell, or fairly valued?
Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
stocks
Bapcor is paying for the sins of its past
Shares plunged over 17% after reporting disappointing results.
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,383.40 | 9.70 | 0.10% |
| CAC 40 | 8,206.07 | 17.48 | 0.21% |
| DAX 40 | 24,258.80 | 427.81 | 1.80% |
| Dow JONES (US) | 46,706.58 | 515.97 | 1.12% |
| FTSE 100 | 9,403.57 | 49.00 | 0.52% |
| HKSE | 25,858.83 | 611.73 | 2.42% |
| NASDAQ | 22,990.54 | 310.57 | 1.37% |
| Nikkei 225 | 49,185.50 | 1,603.35 | 3.37% |
| NZX 50 Index | 13,315.90 | 29.06 | -0.22% |
| S&P 500 | 6,735.13 | 71.12 | 1.07% |
| S&P/ASX 200 | 9,081.60 | 5.70 | 0.06% |
| SSE Composite Index | 3,863.89 | 24.14 | 0.63% |